BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Minemura M, Shimizu Y. Gut microbiota and liver diseases. World J Gastroenterol 2015; 21(6): 1691-1702 [PMID: 25684933 DOI: 10.3748/wjg.v21.i6.1691] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 71] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Di Giacomo S, Briz O, Vitalone A, Di Sotto A. Editorial: Natural Products and Hepatic Health: Light and Shadows. Front Pharmacol 2022;13:868207. [DOI: 10.3389/fphar.2022.868207] [Reference Citation Analysis]
2 Wang Y, Zheng F, Liu S, Luo H. Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome. Gastroenterol Res Pract 2019;2019:9759138. [PMID: 31885549 DOI: 10.1155/2019/9759138] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Dossett ML, Cohen EM, Cohen J. Integrative Medicine for Gastrointestinal Disease. Prim Care 2017;44:265-80. [PMID: 28501229 DOI: 10.1016/j.pop.2017.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
4 Xie G, Wang X, Liu P, Wei R, Chen W, Rajani C, Hernandez BY, Alegado R, Dong B, Li D. Distinctly altered gut microbiota in the progression of liver disease. Oncotarget. 2016;7:19355-19366. [PMID: 27036035 DOI: 10.18632/oncotarget.8466] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 20.2] [Reference Citation Analysis]
5 Tsutsumi T, Okushin K, Enooku K, Fujinaga H, Moriya K, Yotsuyanagi H, Aizaki H, Suzuki T, Matsuura Y, Koike K. Nonstructural 5A Protein of Hepatitis C Virus Interferes with Toll-Like Receptor Signaling and Suppresses the Interferon Response in Mouse Liver. PLoS One 2017;12:e0170461. [PMID: 28107512 DOI: 10.1371/journal.pone.0170461] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
6 Giblot Ducray HA, Globa L, Pustovyy O, Reeves S, Robinson L, Vodyanoy V, Sorokulova I. Mitigation of heat stress-related complications by a yeast fermentate product. Journal of Thermal Biology 2016;60:26-32. [DOI: 10.1016/j.jtherbio.2016.06.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
7 Yu L, Zhao XK, Cheng ML, Yang GZ, Wang B, Liu HJ, Hu YX, Zhu LL, Zhang S, Xiao ZW, Liu YM, Zhang BF, Mu M. Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury. Sci Rep 2017;7:1359. [PMID: 28465509 DOI: 10.1038/s41598-017-01271-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
8 Usami M, Miyoshi M, Yamashita H. Gut microbiota and host metabolism in liver cirrhosis. World J Gastroenterol 2015; 21(41): 11597-11608 [PMID: 26556989 DOI: 10.3748/wjg.v21.i41.11597] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 51] [Article Influence: 8.0] [Reference Citation Analysis]
9 Liu B, Zhang J, Sun P, Yi R, Han X, Zhao X. Raw Bowl Tea (Tuocha) Polyphenol Prevention of Nonalcoholic Fatty Liver Disease by Regulating Intestinal Function in Mice. Biomolecules. 2019;9. [PMID: 31480575 DOI: 10.3390/biom9090435] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
10 Caligiuri A, Gentilini A, Marra F. Molecular Pathogenesis of NASH. Int J Mol Sci. 2016;17. [PMID: 27657051 DOI: 10.3390/ijms17091575] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 13.2] [Reference Citation Analysis]
11 Grąt M, Wronka KM, Krasnodębski M, Masior Ł, Lewandowski Z, Kosińska I, Grąt K, Stypułkowski J, Rejowski S, Wasilewicz M, Gałęcka M, Szachta P, Krawczyk M. Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis. Transplant Proc 2016;48:1687-91. [PMID: 27496472 DOI: 10.1016/j.transproceed.2016.01.077] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 17.2] [Reference Citation Analysis]
12 Portincasa P, Bonfrate L, Khalil M, Angelis MD, Calabrese FM, D’amato M, Wang DQ, Di Ciaula A. Intestinal Barrier and Permeability in Health, Obesity and NAFLD. Biomedicines 2022;10:83. [DOI: 10.3390/biomedicines10010083] [Reference Citation Analysis]
13 Han KH, Hashimoto N, Fukushima M. Relationships among alcoholic liver disease, antioxidants, and antioxidant enzymes. World J Gastroenterol 2016; 22(1): 37-49 [PMID: 26755859 DOI: 10.3748/wjg.v22.i1.37] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
14 Bhat M, Arendt BM, Bhat V, Renner EL, Humar A, Allard JP. Implication of the intestinal microbiome in complications of cirrhosis. World J Hepatol 2016; 8(27): 1128-1136 [PMID: 27721918 DOI: 10.4254/wjh.v8.i27.1128] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
15 Su S, Ren Y, Zhang Y, Zhao Y, Xiao E. Antibiotics Disturb Dentin Formation and Differentiation of Dental Pulp Stem Cells: The Role of Microbiota in Cellular Turnover of Mouse Incisor. Stem Cells Int 2020;2020:5154707. [PMID: 33014068 DOI: 10.1155/2020/5154707] [Reference Citation Analysis]
16 Montagner A, Korecka A, Polizzi A, Lippi Y, Blum Y, Canlet C, Tremblay-Franco M, Gautier-Stein A, Burcelin R, Yen YC, Je HS, Al-Asmakh M, Mithieux G, Arulampalam V, Lagarrigue S, Guillou H, Pettersson S, Wahli W. Hepatic circadian clock oscillators and nuclear receptors integrate microbiome-derived signals. Sci Rep 2016;6:20127. [PMID: 26879573 DOI: 10.1038/srep20127] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 11.0] [Reference Citation Analysis]
17 Shimizu Y. Gut microbiota in common elderly diseases affecting activities of daily living. World J Gastroenterol 2018; 24(42): 4750-4758 [PMID: 30479462 DOI: 10.3748/wjg.v24.i42.4750] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
18 Poland JC, Flynn CR. Bile Acids, Their Receptors, and the Gut Microbiota. Physiology (Bethesda) 2021;36:235-45. [PMID: 34159805 DOI: 10.1152/physiol.00028.2020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ishizaki A, Bi X, Nguyen LV, Matsuda K, Pham HV, Phan CTT, Khu DTK, Ichimura H. Effects of Short-Term Probiotic Ingestion on Immune Profiles and Microbial Translocation among HIV-1-Infected Vietnamese Children. Int J Mol Sci 2017;18:E2185. [PMID: 29048352 DOI: 10.3390/ijms18102185] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
20 Albhaisi S, Sanyal AJ. Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. Front Endocrinol (Lausanne) 2021;12:665987. [PMID: 34040583 DOI: 10.3389/fendo.2021.665987] [Reference Citation Analysis]
21 Alves CC, Waitzberg DL, de Andrade LS, Dos Santos Aguiar L, Reis MB, Guanabara CC, Júnior OA, Ribeiro DA, Sala P. Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver. Front Microbiol 2017;8:2010. [PMID: 29089934 DOI: 10.3389/fmicb.2017.02010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
22 Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 2016;65:1109-23. [DOI: 10.1016/j.metabol.2016.05.003] [Cited by in Crossref: 177] [Cited by in F6Publishing: 160] [Article Influence: 29.5] [Reference Citation Analysis]
23 Anand G, Zarrinpar A, Loomba R. Targeting Dysbiosis for the Treatment of Liver Disease. Semin Liver Dis. 2016;36:37-47. [PMID: 26870931 DOI: 10.1055/s-0035-1571276] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
24 Ahlawat S, Asha, Sharma KK. Gut-organ axis: a microbial outreach and networking. Lett Appl Microbiol 2021;72:636-68. [PMID: 32472555 DOI: 10.1111/lam.13333] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
25 Marino L, Jornayvaz FR. Endocrine causes of nonalcoholic fatty liver disease. World J Gastroenterol 2015; 21(39): 11053-11076 [PMID: 26494962 DOI: 10.3748/wjg.v21.i39.11053] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
26 García-Castillo V, Sanhueza E, McNerney E, Onate SA, García A. Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle. J Med Microbiol 2016;65:1347-62. [PMID: 27902422 DOI: 10.1099/jmm.0.000371] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
27 Hui H, Wu Y, Zheng T, Zhou S, Tan Z. Bacterial Characteristics in Intestinal Contents of Antibiotic-Associated Diarrhea Mice Treated with Qiweibaizhu Powder. Med Sci Monit 2020;26:e921771. [PMID: 32398636 DOI: 10.12659/MSM.921771] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
28 Manne V, Handa P, Kowdley KV. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Clin Liver Dis 2018;22:23-37. [PMID: 29128059 DOI: 10.1016/j.cld.2017.08.007] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 16.2] [Reference Citation Analysis]
29 Sehgal R, Bedi O, Trehanpati N. Role of Microbiota in Pathogenesis and Management of Viral Hepatitis.Front Cell Infect Microbiol. 2020;10:341. [PMID: 32850467 DOI: 10.3389/fcimb.2020.00341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
30 Sung H, Kim SW, Hong M, Suk KT. Microbiota-based treatments in alcoholic liver disease. World J Gastroenterol 2016; 22(29): 6673-6682 [PMID: 27547010 DOI: 10.3748/wjg.v22.i29.6673] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
31 Di Ciaula A, Baj J, Garruti G, Celano G, De Angelis M, Wang HH, Di Palo DM, Bonfrate L, Wang DQ, Portincasa P. Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk. J Clin Med 2020;9:E2648. [PMID: 32823983 DOI: 10.3390/jcm9082648] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
32 Zhuge A, Li B, Yuan Y, Lv L, Li Y, Wu J, Yang L, Bian X, Wang K, Wang Q, Yan R, Zhu X, Li L. Lactobacillus salivarius LI01 encapsulated in alginate-pectin microgels ameliorates D-galactosamine-induced acute liver injury in rats. Appl Microbiol Biotechnol 2020;104:7437-55. [PMID: 32666187 DOI: 10.1007/s00253-020-10749-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Del Bas JM, Guirro M, Boqué N, Cereto A, Ras R, Crescenti A, Caimari A, Canela N, Arola L. Alterations in gut microbiota associated with a cafeteria diet and the physiological consequences in the host. Int J Obes (Lond) 2018;42:746-54. [PMID: 29167556 DOI: 10.1038/ijo.2017.284] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
34 Kameli N, Borman R, Lpez-Iglesias C, Savelkoul P, Stassen FRM. Characterization of Feces-Derived Bacterial Membrane Vesicles and the Impact of Their Origin on the Inflammatory Response. Front Cell Infect Microbiol 2021;11:667987. [PMID: 34026664 DOI: 10.3389/fcimb.2021.667987] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
35 Elsalem L, Jum'ah AA, Alfaqih MA, Aloudat O. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives. Clin Exp Gastroenterol 2020;13:151-85. [PMID: 32440192 DOI: 10.2147/CEG.S243337] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
36 Kassa Y, Million Y, Gedefie A, Moges F. Alteration of Gut Microbiota and Its Impact on Immune Response in Patients with Chronic HBV Infection: A Review. Infect Drug Resist 2021;14:2571-8. [PMID: 34262302 DOI: 10.2147/IDR.S305901] [Reference Citation Analysis]
37 Xu Y, Zha H, Chen W, Cao H, Li L. Recovery Dynamics of Intestinal Bacterial Communities of CCl4-Treated Mice with or without Mesenchymal Stem Cell Transplantation over Different Time Points. Biomed Res Int 2020;2020:1673602. [PMID: 33123564 DOI: 10.1155/2020/1673602] [Reference Citation Analysis]
38 Cardoneanu A, Cozma S, Rezus C, Petrariu F, Burlui AM, Rezus E. Characteristics of the intestinal microbiome in ankylosing spondylitis. Exp Ther Med 2021;22:676. [PMID: 33986841 DOI: 10.3892/etm.2021.10108] [Reference Citation Analysis]
39 Alghamdi MA, Redwan EM. Interplay of Microbiota and Citrullination in the Immunopathogenesis of Rheumatoid Arthritis. Probiotics Antimicrob Proteins 2021. [PMID: 34036479 DOI: 10.1007/s12602-021-09802-7] [Reference Citation Analysis]
40 Xue R, Zhang H, Pan J, Du Z, Zhou W, Zhang Z, Tian Z, Zhou R, Bai L. Peripheral Dopamine Controlled by Gut Microbes Inhibits Invariant Natural Killer T Cell-Mediated Hepatitis. Front Immunol 2018;9:2398. [PMID: 30386344 DOI: 10.3389/fimmu.2018.02398] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
41 Tian X, Li R, Jiang Y, Zhao F, Yu Z, Wang Y, Dong Z, Liu P, Li X. Bifidobacterium breve ATCC15700 pretreatment prevents alcoholic liver disease through modulating gut microbiota in mice exposed to chronic alcohol intake. Journal of Functional Foods 2020;72:104045. [DOI: 10.1016/j.jff.2020.104045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Ma D, Hu J, Xu W, Wang Y, Wang J, Li L, Wang S, Zhou H, Li Y, Liu L. Phosphoesterase complex modulates microflora and chronic inflammation in rats with alcoholic fatty liver disease. Life Sci 2020;262:118509. [PMID: 33010280 DOI: 10.1016/j.lfs.2020.118509] [Reference Citation Analysis]
43 Peng Z, Liao Y, Chen L, Liu S, Shan Z, Nüssler AK, Yao P, Yan H, Liu L, Yang W. Heme oxygenase-1 attenuates low-dose of deoxynivalenol-induced liver inflammation potentially associating with microbiota. Toxicology and Applied Pharmacology 2019;374:20-31. [DOI: 10.1016/j.taap.2019.04.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
44 Yao X, Yu H, Fan G, Xiang H, Long L, Xu H, Wu Z, Chen M, Xi W, Gao Z, Liu C, Gong W, Yang A, Sun K, Yu R, Liang J, Xie B, Sun S. Impact of the Gut Microbiome on the Progression of Hepatitis B Virus Related Acute-on-Chronic Liver Failure. Front Cell Infect Microbiol 2021;11:573923. [PMID: 33889550 DOI: 10.3389/fcimb.2021.573923] [Reference Citation Analysis]
45 Lamas B, Martins Breyner N, Houdeau E. Impacts of foodborne inorganic nanoparticles on the gut microbiota-immune axis: potential consequences for host health. Part Fibre Toxicol 2020;17:19. [PMID: 32487227 DOI: 10.1186/s12989-020-00349-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 15.5] [Reference Citation Analysis]
46 Miele L, Gasbarrini G, Giorgio V, Gasbarrini A, Grieco A. Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome. Intern Emerg Med 2016;11:3-10. [PMID: 26602387 DOI: 10.1007/s11739-015-1346-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
47 Panebianco C, Potenza A, Andriulli A, Pazienza V. Exploring the microbiota to better understand gastrointestinal cancers physiology. Clin Chem Lab Med 2018;56:1400-12. [PMID: 29630505 DOI: 10.1515/cclm-2017-1163] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
48 Bubnov RV, Drahulian MV, Buchek PV, Gulko TP. High regenerative capacity of the liver and irreversible injury of male reproductive system in carbon tetrachloride-induced liver fibrosis rat model. EPMA J 2018;9:59-75. [PMID: 29515688 DOI: 10.1007/s13167-017-0115-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
49 Aktas B, Aslim B. Gut-lung axis and dysbiosis in COVID-19. Turk J Biol 2020;44:265-72. [PMID: 32595361 DOI: 10.3906/biy-2005-102] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
50 Ma J, Zhou Q, Li H. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. Nutrients. 2017;9. [PMID: 29035308 DOI: 10.3390/nu9101124] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 16.0] [Reference Citation Analysis]
51 Meuser-Batista M, Vacani-Martins N, Cascabulho CM, Beghini DG, Henriques-Pons A. In the presence of Trypanosoma cruzi antigens, activated peripheral T lymphocytes retained in the liver induce a proinflammatory phenotypic and functional shift in intrahepatic T lymphocyte. J Leukoc Biol 2020;107:695-706. [PMID: 32202341 DOI: 10.1002/JLB.3A0220-399RR] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
52 Milosevic I, Vujovic A, Barac A, Djelic M, Korac M, Radovanovic Spurnic A, Gmizic I, Stevanovic O, Djordjevic V, Lekic N, Russo E, Amedei A. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. Int J Mol Sci. 2019;20:395. [PMID: 30658519 DOI: 10.3390/ijms20020395] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 27.3] [Reference Citation Analysis]
53 Carotti S, Guarino MPL, Vespasiani-Gentilucci U, Morini S. Starring role of toll-like receptor-4 activation in the gut-liver axis. World J Gastrointest Pathophysiol 2015; 6(4): 99-109 [PMID: 26600967 DOI: 10.4291/wjgp.v6.i4.99] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
54 Pradhan B, Guha D, Ray P, Das D, Aich P. Comparative Analysis of the Effects of Two Probiotic Bacterial Strains on Metabolism and Innate Immunity in the RAW 264.7 Murine Macrophage Cell Line. Probiotics & Antimicro Prot 2016;8:73-84. [DOI: 10.1007/s12602-016-9211-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
55 Lee S, Lee H, Kim S, Lee J, Ha J, Choi Y, Oh H, Kim Y, Lee Y, Choi KH, Yoon Y. Intestinal Clostridioides difficile Can Cause Liver Injury through the Occurrence of Inflammation and Damage to Hepatocytes. Biomed Res Int 2020;2020:7929610. [PMID: 33005688 DOI: 10.1155/2020/7929610] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Qi X, Yang M, Stenberg J, Dey R, Fogwe L, Alam MS, Kimchi ET, Staveley-O'Carroll KF, Li G. Gut microbiota mediated molecular events and therapy in liver diseases. World J Gastroenterol 2020; 26(48): 7603-7618 [PMID: 33505139 DOI: 10.3748/wjg.v26.i48.7603] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Jiang L, Schnabl B. Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know? Physiology (Bethesda) 2020;35:261-74. [PMID: 32490750 DOI: 10.1152/physiol.00005.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
58 Cheng Y, Li Y, Xiong Y, Zou Y, Chen S, Zhang W, Liu C, Shi Y. Liver-specific knockdown of ANGPTL8 alters the structure of the gut microbiota in mice. Ann Microbiol 2020;70. [DOI: 10.1186/s13213-020-01599-0] [Reference Citation Analysis]
59 Campo L, Eiseler S, Apfel T, Pyrsopoulos N. Fatty Liver Disease and Gut Microbiota: A Comprehensive Update. J Clin Transl Hepatol. 2019;7:56-60. [PMID: 30944821 DOI: 10.14218/jcth.2018.00008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
60 Preveden T, Scarpellini E, Milić N, Luzza F, Abenavoli L. Gut microbiota changes and chronic hepatitis C virus infection. Expert Rev Gastroenterol Hepatol 2017;11:813-9. [PMID: 28621554 DOI: 10.1080/17474124.2017.1343663] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 8.4] [Reference Citation Analysis]
61 Zhao L, Mehmood A, Soliman MM, Iftikhar A, Iftikhar M, Aboelenin SM, Wang C. Protective Effects of Ellagic Acid Against Alcoholic Liver Disease in Mice. Front Nutr 2021;8:744520. [PMID: 34595202 DOI: 10.3389/fnut.2021.744520] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Hu J, Li P, Song Y, Ge YX, Meng XM, Huang C, Li J, Xu T. Progress and prospects of circular RNAs in Hepatocellular carcinoma: Novel insights into their function. J Cell Physiol. 2018;233:4408-4422. [PMID: 28833094 DOI: 10.1002/jcp.26154] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
63 Raza MH, Gul K, Arshad A, Riaz N, Waheed U, Rauf A, Aldakheel F, Alduraywish S, Rehman MU, Abdullah M, Arshad M. Microbiota in cancer development and treatment. J Cancer Res Clin Oncol 2019;145:49-63. [PMID: 30542789 DOI: 10.1007/s00432-018-2816-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
64 Alim A, Li T, Nisar T, Ren D, Liu Y, Yang X. Consumption of two whole kiwifruit (Actinide chinensis) per day improves lipid homeostasis, fatty acid metabolism and gut microbiota in healthy rats. Int J Biol Macromol 2020;156:186-95. [PMID: 32278604 DOI: 10.1016/j.ijbiomac.2020.04.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Harrison CA, Taren D. How poverty affects diet to shape the microbiota and chronic disease. Nat Rev Immunol 2018;18:279-87. [PMID: 29109542 DOI: 10.1038/nri.2017.121] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
66 Tajiri K, Shimizu Y. Gut bacteria may control development of hepatocellular carcinoma. Hepatobiliary Surg Nutr 2017;6:417-9. [PMID: 29312980 DOI: 10.21037/hbsn.2017.07.05] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
67 Dalal R, McGee RG, Riordan SM, Webster AC. Probiotics for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017;2:CD008716. [PMID: 28230908 DOI: 10.1002/14651858.cd008716.pub3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
68 Song D, Yang CS, Zhang X, Wang Y. The relationship between host circadian rhythms and intestinal microbiota: A new cue to improve health by tea polyphenols. Crit Rev Food Sci Nutr 2021;61:139-48. [PMID: 31997655 DOI: 10.1080/10408398.2020.1719473] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
69 Qian Y, Li M, Wang W, Wang H, Zhang Y, Hu Q, Zhao X, Suo H. Effects of Lactobacillus Casei YBJ02 on Lipid Metabolism in Hyperlipidemic Mice. Journal of Food Science 2019;84:3793-803. [DOI: 10.1111/1750-3841.14787] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
70 Meng Z, Gao C, Li X, Shen J, Hong T, He X, Zhu L. Effects of Combined Epidural Anesthesia and General Anesthesia on Cognitive Function and Stress Responses of Elderly Patients Undergoing Liver Cancer Surgery. J Oncol 2021;2021:8273722. [PMID: 34608389 DOI: 10.1155/2021/8273722] [Reference Citation Analysis]
71 Wei X, Jiang S, Zhao X, Li H, Lin W, Li B, Lu J, Sun Y, Yuan J. Community-Metabolome Correlations of Gut Microbiota from Child-Turcotte-Pugh of A and B Patients. Front Microbiol 2016;7:1856. [PMID: 27899923 DOI: 10.3389/fmicb.2016.01856] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
72 Shah P, Muller EEL, Lebrun LA, Wampach L, Wilmes P. Sequential Isolation of DNA, RNA, Protein, and Metabolite Fractions from Murine Organs and Intestinal Contents for Integrated Omics of Host-Microbiota Interactions. Methods Mol Biol 2018;1841:279-91. [PMID: 30259493 DOI: 10.1007/978-1-4939-8695-8_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
73 Tolefree JA, Garcia AJ, Farrell J, Meadows V, Kennedy L, Hargrove L, Demieville J, Francis N, Mirabel J, Francis H. Alcoholic liver disease and mast cells: What's your gut got to do with it? Liver Research 2019;3:46-54. [DOI: 10.1016/j.livres.2019.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
74 Ishikawa A, Weese J, Bracarense A, Alfieri A, Oliveira G, Kawamura O, Hirooka E, Itano E, Costa M. Single aflatoxin B 1 exposure induces changes in gut microbiota community in C57Bl/6 mice. World Mycotoxin Journal 2017;10:249-54. [DOI: 10.3920/wmj2017.2190] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
75 Newsome RC, Yang Y, Jobin C. The microbiome, gastrointestinal cancer, and immunotherapy. J Gastroenterol Hepatol 2021. [PMID: 34820895 DOI: 10.1111/jgh.15742] [Reference Citation Analysis]
76 Utzeri E, Usai P. Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease. World J Gastroenterol 2017; 23(22): 3954-3963 [PMID: 28652650 DOI: 10.3748/wjg.v23.i22.3954] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 29] [Article Influence: 7.4] [Reference Citation Analysis]
77 Wang L, Wan YY. The role of gut microbiota in liver disease development and treatment. Liver Res 2019;3:3-18. [PMID: 32461811 DOI: 10.1016/j.livres.2019.02.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
78 Guarino MPL, Cicala M, Putignani L, Severi C. Gastrointestinal neuromuscular apparatus: An underestimated target of gut microbiota. World J Gastroenterol 2016; 22(45): 9871-9879 [PMID: 28018095 DOI: 10.3748/wjg.v22.i45.9871] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]